Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Blood
|
January 25, 2024
PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway
Hao Gu, Chiqi Chen, Zhi-Shuai Hou, et al.
Science (New York, N.Y.)
|
June 20, 2024
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, et al.
Cancer Discovery
|
May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression
Megan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.
JCI Insight
|
September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer
Fumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Cancer Cell
|
June 14, 2011
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression
Michael C Schmid, Christie J Avraamides, Holly C Dippold, et al.
Nature Communications
|
December 21, 2018
Integrin CD11b activation drives anti-tumor innate immunity
Michael C Schmid, Samia Q Khan, Megan M Kaneda, et al.
Cancer Discovery
|
December 31, 2015
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
Andrew J Gunderson, Megan M Kaneda, Takahiro Tsujikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2021
PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response
Jie Li, Megan M Kaneda, Jun Ma, et al.
Oncogene
|
April 11, 2019
MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages
Michele L Babicky, Megan M Harper, Jeffery Chakedis, et al.
Nature
|
November 8, 2016
PI3Kγ is a molecular switch that controls immune suppression
Megan M Kaneda, Karen S Messer, Natacha Ralainirina, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Blood
|
January 25, 2024
PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway
Hao Gu, Chiqi Chen, Zhi-Shuai Hou, et al.
Science (New York, N.Y.)
|
June 20, 2024
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
Jaroslav Zak, Isaraphorn Pratumchai, Brett S Marro, et al.
Cancer Discovery
|
May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression
Megan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.
JCI Insight
|
September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer
Fumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Cancer Cell
|
June 14, 2011
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression
Michael C Schmid, Christie J Avraamides, Holly C Dippold, et al.
Nature Communications
|
December 21, 2018
Integrin CD11b activation drives anti-tumor innate immunity
Michael C Schmid, Samia Q Khan, Megan M Kaneda, et al.
Cancer Discovery
|
December 31, 2015
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
Andrew J Gunderson, Megan M Kaneda, Takahiro Tsujikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2021
PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response
Jie Li, Megan M Kaneda, Jun Ma, et al.
Oncogene
|
April 11, 2019
MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages
Michele L Babicky, Megan M Harper, Jeffery Chakedis, et al.
Nature
|
November 8, 2016
PI3Kγ is a molecular switch that controls immune suppression
Megan M Kaneda, Karen S Messer, Natacha Ralainirina, et al.
Page
of 11